Is Zeitschrift für Gastroenterologie SCI Indexed? Indexing Status & Metrics

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor

2.06

Citation rate 0.16 390 total citations

h5-index 24 h5 depth signal

Cited share 4.8% 122 of 2,534

Total citations 390 Citation footprint

Metric signal 0.19 External metric anchor

Self-citation 8.5% 33 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

Germany 4,189

Austria 578

United States 290

Switzerland 177

United Kingdom 140

Citing Fields of Research

Liver Diseases 350

Hepatitis 301

Digestive Disorders 265

Liver & Colon Cancer 187

Immunology 112

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 25,696 Articles tracked across the journal lifetime

Indexed publication set 2,534 122 cited publications

Last 12 months 1,143 95.3 publications/month

Open access share 2.0% 23 OA publications in the last year

Leading citing country Germany 4,189 citing publications

Leading citing field Liver Diseases 350 citing publications

Latest tracked publication 16 October 2026 10 recent records available

Coverage & Indexing History

MEDLINE

v9n1, 1971-

PubMed

v9n1, 1971-

Index medicus

Active Coverage

Research Focus & Classification

Indexed Subjects

Digestive Disorders Liver Diseases History Of Medicine Lymphomas Hepatitis

Broad Categories

Gastroenterology Hepatitis Liver Diseases Digestive Disorders Immunology Transplantation Cancer, Autophagy & Apoptosis

MeSH Descriptors

Gastroenterology

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01 16 October 2026

DOI 10.1055/a-2954-8029

Fecal Microbiota Transfer for Recurrent Clostridioides difficile Infection: A Retrospective Single-Center Analysis

Open DOI

Andreas Stallmach, Jan Guse, Katrin Katzer et al.

Clostridioides difficile infection (CDI) is the leading cause of healthcare-associated infectious diarrhea. Despite high initial response rates to antibiotic therapy, recurrence occurs in approximately 20% of patients. Fecal microbiota t...

02 30 September 2026

DOI 10.1055/a-2946-0032

Physician Assistants in gastroenterologischen Kliniken in Deutschland: Ergebnisse einer bundesweiten Befragung von leitenden Ärztinnen und Ärzten sowie von Physician Assistants

Open DOI

Paul-Christoph Zeisler, Marie-Therese Leibenguth, Franziska Barth et al.

Zusammenfassung: Obwohl der Studiengang Physician Assistant (PA) seit 2005 in Deutschland existiert und international etabliert ist, liegen nur wenige Daten zu PAs in der Gastroenterologie vor. Diese Studie soll eine Bestandsaufnahme zu ...

03 23 September 2026

DOI 10.1055/a-2894-7716

Neue Therapieansätze bei MASH: Mechanismen und klinisches Potenzial

Open DOI

Alexander Barton, Jörn M. Schattenberg

Zusammenfassung: Die metabolische Dysfunktion-assoziierte steatotische Lebererkrankung (MASLD) ist eine progrediente Lebererkrankung, gekennzeichnet durch Entzündung, Fibrose und metabolische Dysfunktion. In den letzten Jahren haben sich...

04 23 September 2026

DOI 10.1055/a-2894-7628

MASLD: Established Knowledge and Emerging Directions – Guideline Updates

Open DOI

Elke Roeb, Andreas Geier

Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a major global health challenge, largely driven by the increasing prevalence of obesity and type 2 diabetes mellitus. The disease spectrum ranges from isolated s...

05 23 September 2026

DOI 10.1055/a-2856-2586